Compare Healthpeak Properties Inc. Common Stock (DOC) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Healthpeak Properties Inc. Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Healthpeak Properties Inc. Common Stock trades at $18.55 (market cap $12.87B), while Halozyme Therapeutics Inc. Common Stock trades at $109.67 (market cap $12.58B). The key difference: Healthpeak Properties Inc. Common Stock and Halozyme Therapeutics Inc. Common Stock are close in size by market cap, and Healthpeak Properties Inc. Common Stock pays a 6.54% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Healthpeak Properties Inc. Common Stock for 0 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| DOC | HALO | |
|---|---|---|
Market Cap | $12.87B | $12.58B |
Volume | 5,134,919 | 2,179,278 |
Sector | Real Estate | Health |
52-Week High | $22.82 | $115.22 |
52-Week Low | $15.78 | $61.63 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $21.56B | $14.49B |
Dividend Yield | 6.54% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Healthpeak Properties Inc. Common Stock
Healthpeak Properties is a healthcare real estate investment trust in the United States. It owns, operates, and develops outpatient medical, laboratory, and senior housing properties.
Read more on DOC →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
